X4 Pharmaceuticals Inc (NASDAQ: XFOR) is -31.17% lower on its value in year-to-date trading and has touched a low of $0.26 and a high of $1.60 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The XFOR stock was last observed hovering at around $0.61 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.58, the stock is 10.61% and 14.77% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.43 million and changing -5.59% at the moment leaves the stock -27.51% off its SMA200. XFOR registered -22.39% loss for a year compared to 6-month loss of -39.89%. The firm has a 50-day simple moving average (SMA 50) of $0.50158 and a 200-day simple moving average (SMA200) of $0.79766.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 56.65% gain in the last 1 month and extending the period to 3 months gives it a -19.37%, and is -10.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 18.66% over the week and 18.65% over the month.
X4 Pharmaceuticals Inc (XFOR) has around 93 employees, a market worth around $98.42M and $1.12M in sales. Profit margin for the company is -1492.34%. Distance from 52-week low is 120.94% and -63.93% from its 52-week high. The company has generated returns on investments over the last 12 months (-12.27%).
with sales reaching $1.06M over the same period.The EPS is expected to grow by 77.49% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
X4 Pharmaceuticals Inc (XFOR) Top Institutional Holders
126.0 institutions hold shares in X4 Pharmaceuticals Inc (XFOR), with institutional investors hold 68.45% of the company’s shares. The shares outstanding are 168.51M, and float is at 117.85M with Short Float at 10.61%. Institutions hold 67.66% of the Float.
The top institutional shareholder in the company is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC with over 16.92 million shares valued at $9.81 million. The investor’s holdings represent 8.4582% of the XFOR Shares outstanding. As of 2024-06-30, the second largest holder is NEA MANAGEMENT COMPANY, LLC with 14.99 million shares valued at $8.69 million to account for 7.4937 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 10.68 million shares representing 5.3382% and valued at over $6.19 million, while VANGUARD GROUP INC holds 4.1452 of the shares totaling 8.29 million with a market value of $4.81 million.
X4 Pharmaceuticals Inc (XFOR) Insider Activity
The most recent transaction is an insider sale by Ragan Paula, the company’s President and CEO. SEC filings show that Ragan Paula sold 31,897 shares of the company’s common stock on Nov 15 ’24 at a price of $0.39 per share for a total of $12583.0. Following the sale, the insider now owns 0.99 million shares.
Still, SEC filings show that on Oct 15 ’24, Ragan Paula (President and CEO) disposed off 31,897 shares at an average price of $0.56 for $17926.0. The insider now directly holds 1,025,816 shares of X4 Pharmaceuticals Inc (XFOR).
